10 Biotech Trades for Second Half of 2011

Description:

According to Adam Feuerstein, "The biotech calendar for the second half of 2011 is filled with drug approval decisions and clinical trial outcomes, enough to keep biotech stocks jumping for the remainder of the year." Read more here.

>>Also: 10 Cheap Biotech Stocks That Could Soar

>>Also: 5 Dow Stocks Likely to Rise After Earnings

Portfolio not tracked.

Most Viewed Portfolios

View All

Articles

Hedge Funds Hate These 5 Stocks -- Should You?

07.23.14 | 10:50 AM

BALTIMORE (Stockpickr) -- There's nothing hedge fund managers love more than talking their books Professional investors relish every opportunity to...

4 Stocks Under $10 Making Big Moves Higher

07.23.14 | 07:38 AM

DELAFIELD, Wis. (Stockpickr) -- At Stockpickr, we track daily portfolios of stocks that are the biggest percentage gainers and the biggest percenta...

More Articles
blog comments powered by Disqus
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter